Amedisys

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Amedisys reports robust Q4 earnings, eyes growth amidst operational challenges

Amedisys showcases strong financial performance and strategic initiatives for 2023, focusing on growth and operational optimization.
Despite challenges like labor market issues and operational hurdles, the company remains confident in its growth strategies and talent management.
Opportunities in negotiations with payers, talent acquisition, and operational enhancements position Amedisys for continued success and revenue growth.
With a positive outlook for 2023 and a resilient approach to challenges, Amedisys is poised for steady growth and operational improvements.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

BATON ROUGE, La., Dec. 29, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high-acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, at 3:45 p.m. EST.

Amedisys to Present at the 40th Annual J.P. Morgan Healthcare Conference

Altice USA

Chegg

CRISPR Therapeutics

Frontdoor Inc.

Open Lending Corp

Pan American Silver

Royal Philips

Pinterest

StoneCo

If you're looking for bargain stocks to buy that are down 30% or more in 2021, that's not an easy task. Here are 10 that fit the bill.

10 Bargain Stocks to Buy After Falling 30% in 2021

Amedisys (AMED) reported earnings 30 days ago. What's next for the stock?

Why Is Amedisys (AMED) Down 22.9% Since Last Earnings Report?

BATON ROUGE, La., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer will present at the Bank of America Securities 2021 Virtual Healthcare Conference on December 6 at 9:00 a.m. Eastern.

Amedisys to Present at the Bank of America Securities 2021 Virtual Healthcare Conference

BATON ROUGE, La., Nov. 19, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and high acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer will present at the Stephens Annual Investment Conference on December 3rd at 10:00 am Eastern.

Amedisys to Present at the Stephens Annual Investment Conference

PITTSBURGH and HERSHEY, Pa. and NASHVILLE, Tenn.

Penn State Health Partners with Highmark Health and Contessa to Launch Home Recovery Care, a new At-Home Option for Patients

BATON ROUGE, La., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer and Chris Gerard, President and Chief Operating Officer and Scott Ginn, Executive Vice President and Chief Financial Officer will present at the Jefferies London Healthcare Conference on November 18th at 3:00 pm Eastern.

Amedisys to Present at the Jefferies London Healthcare Conference

Amedisys (AMED) reports better-than-expected earnings for the third quarter on strong growth in the Home Health segment.

Amedisys (AMED) Tops Q3 Earnings Estimates, Slashes '21 View

Amedisys, Inc's (AMED) CEO Paul Kusserow on Q3 2021 Results - Earnings Call Transcript

Amedisys (AMED) delivered earnings and revenue surprises of 12.50% and -2.65%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Beats Q3 Earnings Estimates

BATON ROUGE, La., Nov. 02, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and nine-month periods ended September 30, 2021.

Amedisys Reports Third Quarter 2021 Financial Results Updates 2021 Guidance

BATON ROUGE, La., Oct. 25, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of home health, hospice, personal care and higher acuity care services, today announced that Paul B. Kusserow, Chairman and Chief Executive Officer, and Chris Gerard, President and Chief Operating Officer, and Scott Ginn, Executive Vice President and Chief Financial Officer, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on November 9 at 12:10 p.m. Eastern.

Amedisys to Present at the Credit Suisse 30th Annual Virtual Healthcare Conference

BATON ROUGE, La., Oct. 20, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has closed on its acquisition of regulatory assets that allow the Company to establish home health care centers to fully service and expand the Charlotte and Raleigh, N.C. markets.

Amedisys to Open Home Health Care Centers in Charlotte and Raleigh, N.C.

Encompass Health

EHC vs. AMED: Which Stock Is the Better Value Option?

EHC or AMED: Which Is the Better Value Stock Right Now?

Last month, we discussed that Amedisys stock price could rebound over a one-month period after falling 3% in a week, based on its historical performance. However, AMED stock has seen a further decline of over 9% since then, and it is down 5% in the last five trading days.

Can Amedisys Stock Rebound After A 5% Fall In A Week?

BATON ROUGE, La., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading provider of quality home health, hospice and personal care, has signed a definitive agreement to acquire regulatory assets that allow the Company to establish home health care centers to fully service and expand the Charlotte and Raleigh, N.C. markets.

Amedisys to Acquire Home Health Regulatory Assets in Charlotte and Raleigh, N.C.

Amedisys (AMED) Down 6.5% Since Last Earnings Report: Can It Rebound?

EHC vs. AMED: Which Stock Should Value Investors Buy Now?

The stock price of Amedisys, a home-health and hospice company, reached its 52-week low of $175 in yesterday's trading session. AMED stock has seen a gradual decline from levels of over $310 in Jan and Feb this year to levels of around $250 earlier this month, before a recent sell-off in the stock.

Will Amedisys Stock Rebound After Hitting Its 52-Week Low?

The prolonged and lingering impact of COVID-19 on Amedisys (AMED) Hospice business has hampered its ability to grow at the earlier-projected rates.

Amedisys (AMED) Suffers From Low Occupancy Amid Pandemic

Amedisys, Inc. (AMED) CEO Paul Kusserow on Q2 2021 Results - Earnings Call Transcript

The company provided disappointing full-year guidance.

Why Amedisys Stock Is Crashing Today

Amedisys (AMED) reports better-than-expected earnings for the second quarter with strong performance in Home Health and Hospice segments.

Amedisys (AMED) Q2 Earnings Beat Estimates, Margins Grow

Amedisys (AMED) delivered earnings and revenue surprises of 3.05% and -0.09%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Amedisys (AMED) Beats Q2 Earnings Estimates

BATON ROUGE, La., Aug. 04, 2021 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three and six-month periods ended June 30, 2021.

Amedisys Reports Second Quarter 2021 Financial Results, Closing of Contessa Acquisition, Expansion of Credit Facility and Authorization of New $100 Million Share Repurchase Program

News for Amedisys Stock (AMED)